Trump's planning for US rollout of coronavirus vaccine falling short, officials warn

As scientists and pharmaceutical companies work at breakneck speed to develop a vaccine for the novel coronavirus, public health officials and senior US lawmakers are sounding alarms about the Trump administration's lack of planning for its nationwide distribution. The federal government traditionally plays a principal role in funding and overseeing the manufacturing and distribution of new vaccines, which often draw on scarce ingredients and need to be made, stored and transported carefully.